Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Export
Sort by: Relevance
  • New
  • Addendum
  • 10.1016/j.resinv.2025.101366
Corrigendum to "Transcutaneous CO2 and O2 monitoring during walking with a high-flow nasal cannula in patients with chronic obstructive pulmonary disease" [Respir Invest, Volume 63, Issue 5, September 2025, Pages 887-897
  • Jan 10, 2026
  • Respiratory investigation
  • Akira Umeda + 21 more

  • New
  • Research Article
  • 10.1016/j.resinv.2025.101363
All-case post-marketing surveillance of delamanid for treating multidrug-resistant pulmonary tuberculosis in Japan.
  • Jan 9, 2026
  • Respiratory investigation
  • Toru Mori + 10 more

  • New
  • Research Article
  • 10.1016/j.resinv.2025.101357
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial.
  • Jan 9, 2026
  • Respiratory investigation
  • Kozo Morimoto + 12 more

  • New
  • Research Article
  • 10.1016/j.resinv.2026.101368
Identifying high-risk smokers without airflow limitation using new COPD criteria: pooled analysis of two Japanese cohorts.
  • Jan 8, 2026
  • Respiratory investigation
  • Naoya Tanabe + 10 more

  • New
  • Research Article
  • 10.1016/j.resinv.2026.101367
Epidemiology of interstitial lung diseases in Japan: A nationwide database analysis.
  • Jan 8, 2026
  • Respiratory investigation
  • Koichi Miyashita + 12 more

  • New
  • Research Article
  • 10.1016/j.resinv.2025.101360
Summary of the Japanese Respiratory Society guidelines for the diagnosis and treatment of asthma and chronic obstructive pulmonary disease overlap 2023 (2nd edition).
  • Jan 7, 2026
  • Respiratory investigation
  • Shigeo Muro + 5 more

  • New
  • Research Article
  • 10.1016/j.resinv.2025.101341
Impact of hospitalization on health-related quality of life in patients receiving home oxygen therapy: Insights of the Japanese white paper on home respiratory care 2024
  • Jan 1, 2026
  • Respiratory Investigation
  • Satoshi Hamada + 10 more

  • New
  • Research Article
  • 10.1016/j.resinv.2025.101362
IL1RL1 rs11685480 polymorphism is associated with IL-33/IL1RL1 pathway activity and asthma severity in a Japanese population.
  • Jan 1, 2026
  • Respiratory investigation
  • Keita Hirai + 6 more

  • New
  • Research Article
  • 10.1016/j.resinv.2025.101337
How to choose a biologic agent considering comorbidities of bronchial asthma.
  • Jan 1, 2026
  • Respiratory investigation
  • Masamichi Itoga + 1 more

  • New
  • Research Article
  • 10.1016/j.resinv.2025.101354
Effect of large-volume intrapleural saline lavage for empyema: a single-center, prospective cohort study.
  • Jan 1, 2026
  • Respiratory investigation
  • Masanori Kawataki + 7 more